Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

Stepping out

Securing behavioural change has become a global obsession that’s driving a step change in healthcare communications

Bristol Myers Squibb logo

Bad news for Innate Pharma as BMS-backed drug stumbles

Lirilumab combination fails to show additional benefit in SCCHN patients

- PMLiVE

EC expands Janssen’s prostate cancer drug reach

Zytiga plus predinson/prednisolone will now treat mHSPC patients

Inceptua Medicines Access appoints senior new-hires

The new speciality business unit appoints senior project manager and office manager

Realm Therapeutics appoints Sandy Zweifach as non-executive director

But Matthew Hammond and Daniel Hegglin retire

- PMLiVE

GSK’s ViiV gets US okay for two-drug HIV regimen

Juluca is a combination of ViiV’s Tivicay and Janssen’s Edurant

- PMLiVE

Is AI changing the future of healthcare?

How technology is playing a big role in healthcare

- PMLiVE

What value for innovation in an era dominated by affordability?

Pharma can collaborate but must be clear about its motives

- PMLiVE

MHRA joins Instagram as part of Yellow Card drive

UK medicines regulator follows in the footsteps of NICE in using the channel

- PMLiVE

Novartis’ orphan drug Tasigna wins EU expanded indication

The CML medication can now treat paediatric patients

- PMLiVE

Lucid Group bolster their commitment to agile working with the appointment of a new Head of Operations and Facilities

Thriving businesses often meet unique challenges when transitioning from a start-up to an established medium-sized company. With its numerous successes and exponential expansion over the last ten years, Lucid recognise...

Lucid Group Communications Limited

- PMLiVE

First Herceptin biosimilar cleared in Europe

Ontruzant is approved for all the same indications as Roche’s blockbuster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links